MedTrace Logo

Early Medication Discontinuation and Long-term Clinical Outcome in FEP

NCT01926340 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 178

Last updated 2017-08-07

No results posted yet for this study

Summary

The study aims to examine the relationship between early maintenance therapy decisions in first episode psychosis, and the subsequent long-term clinical outcome at 9-10 years by comparing a group of patients who were randomized to discontinue (placebo) or continue medication (quetiapine) in the early stage of their psychotic disorders.

Conditions

Sponsors & Collaborators

  • Research Grants Council, Hong Kong

    collaborator OTHER

  • AstraZeneca

    collaborator INDUSTRY

  • Food and Health Bureau, Hong Kong

    collaborator OTHER_GOV

  • University of British Columbia

    collaborator OTHER

  • Professor Eric Y.H. Chen

    lead OTHER

Principal Investigators

  • Eric YH Chen, MD · The University of Hong Kong

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-12-31
Completion
2015-03-31

Countries

  • Hong Kong

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01926340 on ClinicalTrials.gov